Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems
Wall Street Journal
Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.
https://www.wsj.com/articles/novo-nordisk-says-ozempic-drug-cuts-risk-of-kidney-problems-c9871079